-
Product Insights
Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Ovarian Cancer Pipeline Drugs Market Overview Ovarian cancer is any cancerous growth that may occur in different parts of the ovary. The majority of ovarian cancers arise from the epithelium (outer lining) of the ovary. Signs and symptoms of ovarian cancer include pelvic discomfort or pain, indigestion, gas or nausea, and changes in bowel habits, such as constipation, loss of appetite, and low back pain. The predisposing factors include age and family history. Treatment includes surgery, chemotherapy, and radiation therapy....
-
Product Insights
Kidney Cancer (Renal Cell Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Kidney Cancer Pipeline Products Market Report Overview Kidney cancer also called renal cancer is a disease in which kidney cells become malignant (cancerous) and grows out of control, forming a tumor. Symptoms include blood in urine, loss of appetite, fever that lasts for weeks, extreme fatigue, anemia, shortness of breath, and bone pain. Treatment includes surgery, radiation therapy, and chemotherapy. The kidney cancer pipeline market research report provides comprehensive information on the therapeutics under development for kidney cancer, complete with...
-
Sector Analysis
Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that represents about 15% of all lung cancers. The condition is marked by an exceptionally high proliferative rate, a strong predilection for early metastasis, and a poor prognosis. Most patients have metastatic disease at diagnosis, with only one-third presenting earlier-stage disease that is amenable to potentially curative multimodality therapy. The small cell lung cancer marketed and pipeline drugs assessment report provides a data-driven overview of the current and...
-
Sector Analysis
Pancreatic Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Pancreatic cancer is the seventh leading cause of cancer deaths worldwide. Pancreatic cancer occurs when cells in the pancreas develop mutations in their DNA and grow uncontrollably. These accumulating cells form a tumor. Untreated pancreatic cancer spreads to nearby organs and blood vessels. Pancreatic adenocarcinoma (PDAC) or pancreatic exocrine cancer is the most common type of pancreatic cancer and begins in the cells that line the ducts of the pancreas. The pancreatic cancer marketed and pipeline drugs assessment report provides...
-
Product Insights
Acute Lymphoblastic Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Acute Lymphoblastic Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Acute Lymphoblastic Lymphoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Lymphoblastic Lymphoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news...
-
Product Insights
Acute Promyelocytic Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Acute Promyelocytic Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Acute Promyelocytic Leukemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Promyelocytic Leukemia, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news...
-
Product Insights
Cutaneous T-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Cutaneous T-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Cutaneous T-Cell Lymphoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cutaneous T-Cell Lymphoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news...
-
Product Insights
Adenocarcinoma Of The Gastroesophageal Junction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Adenocarcinoma Of The Gastroesophageal Junction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Adenocarcinoma Of The Gastroesophageal Junction pipeline landscape. The report provides comprehensive information on the therapeutics under development for Adenocarcinoma Of The Gastroesophageal Junction, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research...
-
Product Insights
Anaplastic Large Cell Lymphoma (ALCL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Anaplastic Large Cell Lymphoma (ALCL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Anaplastic Large Cell Lymphoma (ALCL) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anaplastic Large Cell Lymphoma (ALCL), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research...
-
Product Insights
Anaplastic Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Anaplastic Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Anaplastic Thyroid Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anaplastic Thyroid Cancer, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.